Claus Meyer
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 87
- Acute Myeloid Leukemia Research 86
-
- Acute Lymphoblastic Leukemia research 82
- Co-authors
- Rolf Marschalek (118 shared papers)Hans Günter Drexler (11 shared papers)Björn Schneider (10 shared papers)Rob Pieters (11 shared papers)Thomas Burmeister (11 shared papers)Jacques J. M. van Dongen (4 shared papers)Theo Dingermann (9 shared papers)Oskar A. Haas (7 shared papers)
In The Last Decade
Claus Meyer
144 papers receiving 4.2k citations
Claus Meyer's Hit Papers
Peers
Comparison fields: 5 of 70
- Hematology 1.9k
- Public Health, Environmental and Occupational Health 1.8k
- Genetics 182
- Molecular Biology 898
- Cancer Research 188
Countries citing papers authored by Claus Meyer
This map shows the geographic impact of Claus Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Meyer more than expected).
Fields of papers citing papers by Claus Meyer
This network shows the impact of papers produced by Claus Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Meyer. The network helps show where Claus Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Claus Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The MLL recombinome of acute leukemias in 2017 Hit paper breakdown → | 2017 | 530 |
| 2 | The MLL recombinome of acute leukemias in 2013 Hit paper breakdown → | 2013 | 402 |
| 3 | 2009 | 320 | |
| 4 | 2006 | 218 | |
| 5 | 2011 | 191 | |
| 6 | 2004 | 159 | |
| 7 | The KMT2A recombinome of acute leukemias in 2023 Hit paper breakdown → | 2023 | 147 |
| 8 | 2009 | 127 | |
| 9 | 2007 | 101 | |
| 10 | 2011 | 87 | |
| 11 | 2009 | 85 | |
| 12 | 2010 | 85 | |
| 13 | 2009 | 84 | |
| 14 | 2007 | 66 | |
| 15 | 1999 | 63 | |
| 16 | 2006 | 57 | |
| 17 | 2007 | 53 | |
| 18 | 2010 | 52 | |
| 19 | 2015 | 51 | |
| 20 | 2013 | 50 |
About Claus Meyer
Claus Meyer is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Biotechnology, having authored 148 papers that have together received 4.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (86 papers), Acute Lymphoblastic Leukemia research (82 papers), Retinoids in leukemia and cellular processes (5 papers), Genomic variations and chromosomal abnormalities (4 papers), Chromatin Remodeling and Cancer (4 papers), Marine Sponges and Natural Products (2 papers), Melanoma and MAPK Pathways (1 paper) and Neurofibromatosis and Schwannoma Cases (1 paper). The work is most often cited by research in Hematology (1.9k citations), Public Health, Environmental and Occupational Health (1.8k citations), Genetics (182 citations), Molecular Biology (898 citations) and Cancer Research (188 citations). Claus Meyer has collaborated with scholars based in Germany, France and Czechia. Frequent co-authors include Rolf Marschalek, Hans Günter Drexler, Björn Schneider, Rob Pieters, Thomas Burmeister, Jacques J. M. van Dongen, Theo Dingermann, Oskar A. Haas, Mariana Emerenciano and Sabine Strehl. Their work appears in journals such as Leukemia, Blood, Leukemia Research, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.